BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25059502)

  • 21. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
    Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
    Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
    Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
    Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors.
    Ozten O; Zengin Kurt B; Sonmez F; Dogan B; Durdagi S
    Bioorg Chem; 2021 Oct; 115():105225. PubMed ID: 34364052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
    J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
    Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
    Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
    J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ; Bian HL; Wang JW; Shan WG
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
    Alipour M; Khoobi M; Moradi A; Nadri H; Homayouni Moghadam F; Emami S; Hasanpour Z; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Jul; 82():536-44. PubMed ID: 24941128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gypsogenin derivatives: an unexpected class of inhibitors of cholinesterases.
    Heller L; Schwarz S; Weber BA; Csuk R
    Arch Pharm (Weinheim); 2014 Oct; 347(10):707-16. PubMed ID: 25042600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
    Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
    Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
    Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
    J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
    Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of new inhibitors of cholinesterases based on N-phenylcarbamates: In vitro study of inhibitory effect, type of inhibition, lipophilicity and molecular docking.
    Vorčáková K; Májeková M; Horáková E; Drabina P; Sedlák M; Štěpánková Š
    Bioorg Chem; 2018 Aug; 78():280-289. PubMed ID: 29621640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors.
    Imramovský A; Pejchal V; Štěpánková Š; Vorčáková K; Jampílek J; Vančo J; Šimůnek P; Královec K; Brůčková L; Mandíková J; Trejtnar F
    Bioorg Med Chem; 2013 Apr; 21(7):1735-48. PubMed ID: 23462716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-[3,5-Bis(trifluoromethyl)phenyl]-5-bromo-2-hydroxybenzamide Analogues: Novel Acetyl- and Butyrylcholinesterase Inhibitors.
    Krátký M; Jaklová K; Štěpánková Š; Svrčková K; Pflégr V; Vinšová J
    Curr Top Med Chem; 2020; 20(23):2094-2105. PubMed ID: 32814530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases.
    Schwarz S; Lucas SD; Sommerwerk S; Csuk R
    Bioorg Med Chem; 2014 Jul; 22(13):3370-8. PubMed ID: 24853320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.